What is the address of Ine Renckens, Anatomopathologie?

The registered office of Ine Renckens, Anatomopathologie is located at Sint-Gertrudendries(LUB) 2, 3210 Lubbeek.

Is Ine Renckens, Anatomopathologie still active?

Yes. According to the CBE (17 September 2026) Ine Renckens, Anatomopathologie is active, legal situation “Normale toestand”, started on 31 December 2019.

Is Ine Renckens, Anatomopathologie registered on Peppol?

Yes, Ine Renckens, Anatomopathologie is registered on the Peppol network with ID 0208:0740630830.

What is the enterprise number of Ine Renckens, Anatomopathologie?

The enterprise number of Ine Renckens, Anatomopathologie is BE0740630830.

When was Ine Renckens, Anatomopathologie founded?

Ine Renckens, Anatomopathologie was founded on 31 December 2019.

Who are the directors of Ine Renckens, Anatomopathologie?

According to the 2024 annual accounts, the directors of Ine Renckens, Anatomopathologie are: Ine Renckens.

Is Ine Renckens, Anatomopathologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 December 2019; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did Ine Renckens, Anatomopathologie make in 2024?

Ine Renckens, Anatomopathologie posted a profit after taxes of € 119,142 in financial year 2024.

What is the revenue of Ine Renckens, Anatomopathologie?

As a small company, Ine Renckens, Anatomopathologie is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 226,488.

Ine Renckens, Anatomopathologie (Private Limited)

Dossier Ine Renckens, Anatomopathologie, printed on 17 September 2026 from databakkes.be/en/0740630830/ine-renckens-anatomopathologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

Ine Renckens, Anatomopathologie from Lubbeek, company number BE0740630830, closed financial year 2024 with a result of € 119,142 after tax. For that financial year Ine Renckens, Anatomopathologie recorded a gross margin of € 226,488 and equity of € 163,890. Compared with financial year 2023, the result moved from € 105,791 to € 119,142. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 11, 2025.

What it is worth Growing

€ 163,890

▲ 266% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 119,142

▲ 13% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 333,629

▲ 76% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 153,890.

People and assets in 2024

Vehicles and equipment

€ 1,927

▼ 31% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 6 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 393,169

▼ 14% vs 2023

€ 63,629 is repaid this year. At this pace the long-term loan is gone in ≈ 6 years.

Owed to suppliers

€ 4,906

▼ 12% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,774

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 165,161 Gross margin 2021: € 165,161 First fiscal year in the series	€ 206,786 Gross margin 2022: € 206,786 ▲ 25% vs 2021 (€ 165,161) Favourable step	€ 210,973 Gross margin 2023: € 210,973 ▲ 2% vs 2022 (€ 206,786) Favourable step	€ 226,488 Gross margin 2024: € 226,488 ▲ 7% vs 2023 (€ 210,973) Favourable step	▲ 7%
Profit after taxes	€ 72,409 Profit after taxes 2021: € 72,409 First fiscal year in the series	€ 102,604 Profit after taxes 2022: € 102,604 ▲ 42% vs 2021 (€ 72,409) Favourable step	€ 105,791 Profit after taxes 2023: € 105,791 ▲ 3% vs 2022 (€ 102,604) Favourable step	€ 119,142 Profit after taxes 2024: € 119,142 ▲ 13% vs 2023 (€ 105,791) Favourable step	▲ 13%
Equity	€ 211,353 Equity 2021: € 211,353 First fiscal year in the series	€ 313,957 Equity 2022: € 313,957 ▲ 49% vs 2021 (€ 211,353) Favourable step	€ 44,747 Equity 2023: € 44,747 ▼ 86% vs 2022 (€ 313,957) Unfavourable step	€ 163,890 Equity 2024: € 163,890 ▲ 266% vs 2023 (€ 44,747) Favourable step	▲ 266%
Total debts	€ 610,734 Total debts 2021: € 610,734 First fiscal year in the series	€ 531,644 Total debts 2022: € 531,644 ▼ 13% vs 2021 (€ 610,734) Favourable step	€ 727,376 Total debts 2023: € 727,376 ▲ 37% vs 2022 (€ 531,644) Unfavourable step	€ 663,913 Total debts 2024: € 663,913 ▼ 9% vs 2023 (€ 727,376) Favourable step	▼ 9%
Cash	€ 118,968 Cash 2021: € 118,968 First fiscal year in the series	€ 134,662 Cash 2022: € 134,662 ▲ 13% vs 2021 (€ 118,968) Favourable step	€ 189,470 Cash 2023: € 189,470 ▲ 41% vs 2022 (€ 134,662) Favourable step	€ 333,629 Cash 2024: € 333,629 ▲ 76% vs 2023 (€ 189,470) Favourable step	▲ 76%
Retained profit	€ 201,353 Retained profit 2021: € 201,353 First fiscal year in the series	€ 303,957 Retained profit 2022: € 303,957 ▲ 51% vs 2021 (€ 201,353) Favourable step	€ 34,747 Retained profit 2023: € 34,747 ▼ 89% vs 2022 (€ 303,957) Unfavourable step	€ 153,890 Retained profit 2024: € 153,890 ▲ € 119,142 vs 2023 (€ 34,747) Favourable step	▲ € 119,142
Dividend	€ 0 Dividend 2021: € 0 First fiscal year in the series	€ 0 Dividend 2022: € 0 Unchanged (€ 0) Unchanged	€ 375,000 Dividend 2023: € 375,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 375,000) Unchanged	▼ 100%
Bank debt	€ 583,370 Bank debt 2021: € 583,370 First fiscal year in the series	€ 521,074 Bank debt 2022: € 521,074 ▼ 11% vs 2021 (€ 583,370) Favourable step	€ 458,011 Bank debt 2023: € 458,011 ▼ 12% vs 2022 (€ 521,074) Favourable step	€ 393,169 Bank debt 2024: € 393,169 ▼ 14% vs 2023 (€ 458,011) Favourable step	▼ 14%
Balance sheet total	€ 822,087 Balance sheet total 2021: € 822,087 First fiscal year in the series	€ 845,601 Balance sheet total 2022: € 845,601 ▲ 3% vs 2021 (€ 822,087) Unchanged	€ 772,124 Balance sheet total 2023: € 772,124 ▼ 9% vs 2022 (€ 845,601) Unchanged	€ 827,803 Balance sheet total 2024: € 827,803 ▲ 7% vs 2023 (€ 772,124) Unchanged	▲ 7%

Key figures of Ine Renckens, Anatomopathologie, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Ine Renckens, Anatomopathologie?

What happened at Ine Renckens, Anatomopathologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 11, 2025 New annual accounts for financial year 2024: profit of € 119,142 (▲ 13% vs 2023). filed late Source: NBB ↗
Dec 31, 2019 New establishment in Lubbeek. KBO
2019 Ine Renckens became a director. NBB
Dec 31, 2019 Start of the company according to the CBE. KBO

In short

From € 72,409 profit in 2021 to € 119,142 profit in 2024.

Paid € 109,250 in corporate taxes since 2021.

Best year ever: 2024, with € 119,142 profit.

Paid out € 375,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Ine Renckens, Anatomopathologie? We notify you, reason included.

Follow Ine Renckens, Anatomopathologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Ine Renckens

Ine Renckens, Anatomopathologie

Behind Ine Renckens, Anatomopathologie is Ine Renckens.

See the full network in the app

Directors

According to the 2024 annual accounts

Ine Renckens

Director

since 2019

Establishments

Establishment units

Physical locations of this company

Registered office

Sint-Gertrudendries(LUB) 2

3210 Lubbeek

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

associatie anatoompathologie RZ Tienen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0740.630.830
VAT number: BE 0740.630.830
Registered office: Sint-Gertrudendries(LUB) 2, 3210 Lubbeek
Names & denominations: Ine Renckens, Anatomopathologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 31 December 2019
Peppol: Active · Active since 28 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗